Sandoz Wins $70M In Antitrust Suit Over Hypertension Drug
A New Jersey federal court awarded Sandoz Inc. just over $70 million in damages in a case accusing biopharmaceutical firm United Therapeutics Corp. of blocking the sale of a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article